Dr. Khuroo

Dr. Khuroo Dr. Khuroo's Medical Clinic, Sector 1, SK Colony, Qamarwari, Srinagar, Kashmir, J&K (UT), India 190010; telephone 7006277331; 7006177742; 0194-2492398.

Message: Former Faculty Medical ForumIt gives me immense pleasure and a deep sense of nostalgia to write this message fo...
24/07/2026

Message: Former Faculty Medical Forum
It gives me immense pleasure and a deep sense of nostalgia to write this message for the souvenir being published by the Former Medical Faculty Forum, Kashmir. This publication is more than a commemorative volume; it reflects our shared journey, our collective memories, and our enduring commitment to the noble profession of medicine. It brings together colleagues who have devoted the prime years of their lives to the service of humanity, the education of countless medical students, and the advancement of healthcare in Jammu and Kashmir.
Medicine is not merely a profession; it is a calling that demands knowledge, compassion, humility, and unwavering dedication. Those of us who have had the privilege of serving as members of the faculty in our medical institutions have experienced the unique satisfaction of combining patient care with teaching and research. We have had the honor of guiding generations of young students into becoming competent, ethical, and compassionate physicians, and nothing is more gratifying than seeing our former students excel as leaders across the country and around the world.
As we look back over the decades, we recall a period marked by both challenges and achievements. While advances in medical science and technology—from artificial intelligence to digital health—have revolutionized the practice of medicine, they have also reinforced the timeless truth that technology can never replace empathy, ethical conduct, and the human touch. Despite numerous adversities, the healthcare landscape of Kashmir has evolved significantly, with new departments and specialized services expanding through the unwavering dedication of faculty members.
The Former Faculty Medical Forum Kashmir serves as a valuable platform for preserving this rich legacy. Retirement does not diminish one's commitment; rather, it provides an opportunity to contribute through mentorship, community service, and the sharing of wisdom acquired through years of experience. One of the greatest strengths of this forum lies in fostering fellowship and lifelong friendships, allowing us to reconnect and strengthen the bonds forged over years of shared work. It also provides an opportunity to celebrate our predecessors whose dedication laid the strong foundation upon which present-day medical education continues to flourish.
As senior members of the medical fraternity, we have a responsibility to encourage younger colleagues to uphold the highest standards of professionalism. Integrity, honesty, and a commitment to evidence-based practice must remain our guiding principles. The publication of this souvenir serves as a repository of these memories and achievements, preserving institutional memory and strengthening our professional identity.
I wish to acknowledge the tireless efforts of the office bearers and members who have worked diligently to strengthen this Forum. Beyond our professional accomplishments, we should always remember the larger purpose of medicine—the alleviation of human suffering. The gratitude of a recovered patient and the success of a former student are the true rewards of our profession, surpassing any award or recognition.
On a personal note, I feel deeply privileged to have shared this remarkable journey with so many distinguished colleagues. I congratulate the editorial team and all those associated with this publication. May this endeavor become a lasting tradition, strengthening our bonds and inspiring future generations to uphold the noble ideals of medicine.

Hepatitis E Vaccine, HEV 239: A consensus report.  Hepatitis E is our story.  It has a global impact. The hepatitis E va...
24/07/2026

Hepatitis E Vaccine, HEV 239: A consensus report.
Hepatitis E is our story. It has a global impact. The hepatitis E vaccine was conceived in 1999 and culminated in the highly effective product HEV 239 (Hecolin®️) in 2010. Since then, there have been remarkable human trials done, and the vaccine has proven safety, efficacy, and long-term protection. Its reach to India has been considerably delayed. Based on the results of a phase III trial, the vaccine received approval for use in India in August 2025. Welcome news. It was important to define a consensus on its role in India.
Through a delicate and painstaking process, we have completed a consensus report on the use of hepatitis E vaccine, HEV 239, in India. Based on an in-depth literature search (7195 articles), three rounds, and several revisions, a set of 18 statements (Section A: Vaccine safety and efficacy; Section B: Indications) was prepared. 33 senior, experienced, and highly accomplished practicing hepatologists working in 25 tertiary Medical Institutions from ten States in India gave their opinion on each statement for level of evidence; potential benefits and grades of recommendations under the dedicated GRADE system. We set 70% as the threshold for consensus.
The panel concluded that the vaccine is safe and highly effective, providing long-term protection. Based on the consensus, targeted vaccination was recommended for five high-risk scenarios/populations: outbreak-affected groups, hyperendemic pockets, women of childbearing age, patients with CLD, and solid organ transplant recipients. Limitations of the expert consensus report were highlighted, which included: Recent profound demographic and clinical transition of hepatitis E in India and reasons thereof; lack of WHO prequalification; lack of cost-effectiveness studies from India; logistic and financial constraints for widespread use; vaccine hesitancy among doctors, public, and Health administrators; predominance of clinical trials from China: total trials 20-China 11; Bangladesh 4; Sudan 2 (one ongoing); India 1; USA 1; Pakistan 1 (ongoing); safety concerns among pregnant women; lack of data on Children/adolescence, immunosuppressed, sick patients with CLD, etc. and Uncertainty about homologous and cross-genotype protection.
This consensus report provides a framework for deploying the HEV 239 (Hecolin®️) to mitigate disease burden in India while emphasizing the need for future real-world effectiveness and safety data from India.
REFERENCE:
Khuroo MS, Khuroo NS. Clinical Guidelines for Hepatitis E Vaccination in India: An Expert Panel Consensus Report on the Recombinant Hepatitis E Vaccine, HEV 239. Pathogens. 2026;15(8):783.
Website: https://www.mdpi.com/2076-0817/15/8/783
PDF Version: https://www.mdpi.com/2076-0817/15/8/783/pdf

Wonders of Clinical Medicine!Moments of Hope, Hype and Happiness.On a fateful day, a bride entered my busy clinic and wa...
14/07/2026

Wonders of Clinical Medicine!
Moments of Hope, Hype and Happiness.
On a fateful day, a bride entered my busy clinic and wanted to speak to me. She stood in my consultation chamber, confronted me, and spoke, “Doctor sahib, I entered this clinic several years back when I had lost all hope to survive and live. You worked tirelessly for my well-being all these years, gave me hundreds of counseling sessions, and treated me with compassion. Over the years, I gradually recovered, gained confidence, and improved my health. I slowly developed the will to live and return to normalcy. A pending marriage proposal, once a distant dream, has become a reality, and the moment has arrived. Kindly accept the invitation to my marriage. It is my earnest wish that you attend my marriage ceremony.” I listened to her in silence. The whole clinic staff, patients, and their caregivers (attendants) were stunned.
On her marriage day, I drove hours to reach her home and attended the ceremony. She herself (in the bride's attire) served me the meal and sat beside me for over an hour while I was in her house.
A few months later, she again attended my clinic (this time with a proper appointment) and wanted treatment for emesis gravidarum (vomiting of pregnancy). An obstetric ultrasound revealed a sac with a fetus showing an actively beating heart.
We hope and pray for a successful pregnancy and the birth of a new soul. Ameen.

Tajweed Essentials: Mastering the Art of Quranic Recitation May Allah grant us the strength and wisdom to perfect our re...
07/07/2026

Tajweed Essentials: Mastering the Art of Quranic Recitation
May Allah grant us the strength and wisdom to perfect our recitation of Al-Qur'an, and shower His endless blessings upon us. Ameen!

Salt Tea (Noon Chai) and Cancer Esophagus in the Kashmiri Population: Cause and Effect.Dear Viewers: Let Science speak f...
25/06/2026

Salt Tea (Noon Chai) and Cancer Esophagus in the Kashmiri Population: Cause and Effect.
Dear Viewers: Let Science speak for itself.
The data that form the basis of these statements have been meticulously collected over decades. These are published in high-ranking International Journals and are heavily cited by the International medical fraternity. Each statement is followed by a supportive publication.
Disease Burden
The incidence of esophageal cancer in Kashmir is among the highest in the world. The age-standardized incidence rate (ASIR) in the valley is 43.6 per 100,000 per year for men and 27.9 per 100,000 for women. (1) The burden of esophageal cancer in Kashmir is 3 to 6 times higher than in other major Indian metropolitan areas and the West. However, the incidence in Kashmir is comparable to other regions within the Asian Cancer esophagus belt, such as the Caspian littoral of Iran and the Henan and Shanxi provinces of China. (1) We have evidence that healthy adults have a high occurrence of esophagitis, dysplasia, and carcinoma in situ, which finally culminates in cancer. The data generated show that extensive exposure to nitrates and aliphatic amines in food items is related to the occurrence of cancer in this population. (2, 3) In a meticulously conducted case-control study, five food items were associated with esophageal cancer. These include 1. Salt tea (>5 cups per day; OR 5.93), 2. Smoking (OR 4.75), 3. milk (30g/day; OR 1.92), and 5. fruits (

CitationDistinguished Alumnus Mega Alumni Meet 2025University of Kashmir
21/06/2026

Citation
Distinguished Alumnus
Mega Alumni Meet 2025
University of Kashmir

Guest of Honour. Opening Ceremony.53rd Annual Conference of the Indian Immunology Society (IIS).IMMUNCON-2026.Venue: SKI...
19/06/2026

Guest of Honour.
Opening Ceremony.
53rd Annual Conference of the Indian Immunology Society (IIS).
IMMUNCON-2026.
Venue: SKICC
Date: 10th June 2026.
Organizing Chairperson: Prof. Dil Afroz
SKIMS, Soura, Kashmir, J&K (UT), India.

My address to the Society.
Hon'ble Prof. Gobardhan Das, Full-time member, NITI Aayog, the Chief Guest of IMMUNCON 2026; Distinguished Prof. Anil Avasthi, President of the Indian Immunology Society; Respected Prof. Mohd Ashraf Ganie, Director, SKIMS, and the Man in the Driver’s Seat; My dear Prof. Fazul Qadir Parray, the man of dignity and integrity, loved by all; Prof. Bashir Ahmad Fomda, Dean SKIMS, whom I admire for his high values in Microbiology; Prof. Dil Afroz, the dynamic leader of today's function; Esteemed Foreign delegates; Brilliant minds of the Indian Immunology Society; Esteemed faculty of SKIMS; Fellow clinicians.

It is a profound honor for me to stand before you today in the breathtaking surroundings of Srinagar for the inauguration of IMMUNOCON 2026.

As a practicing physician and hepatologist, I believe that Immunology forms the foundation of modern medicine by elucidating how the immune system defends against pathogens. and has given us life-saving vaccines, monoclonal antibodies, and advanced treatments for autoimmune disorders. It has revolutionized modern healthcare, enabling organ transplants, taming autoimmune diseases, and developing revolutionary cancer immunotherapies.

Dear friends and colleagues. My love for immunology started early in my career. In the eighties, during my journey to discover hepatitis E, I came to know and collaborate for years with two stalwarts, namely Dr. Alferd Prince at New York Blood Center and Bob Purcell at NIH, and developed a love and respect for the specialty and its members. Very soon in 1983, a young man took a flight from the US to enter my ward at SKIMS and wanted to pursue his future in hepatitis E research. Dr. Shahid Jameel at ICGEB made all of us proud with his dedicated work on hepatitis E virus, and I feel nostalgic about having been involved in his career development. While collaborating with him at ICGEB, I came to know and interact with a stalwart in Immunology, namely Prof. G.P. Talwar at the National Institute of Immunology, New Delhi.

To my fellow members at SKIMS, I would like to divulge a secret. In 1993, when I took over as Director of SKIMS, I, against all MCI norms, started a PhD program in basic sciences, including Immunology. To those who opposed, I wrote that an Institution of the stature of SKIMS cannot survive in the scientific world without basic research in immunology. I am proud to see the fruits of that endeavor, and these departments, which I nurtured against all odds, have made all of us proud. While at SKIMS, I led many PhD research protocols. One among them was to train a technologist in the molecular biology of the hepatitis E virus. Dr. Saleem Kamili, who completed his PhD with me, has made us proud by taking a lead position in hepatitis at the CDC in Atlanta, USA.

To my friend Dr. Mudasir Andrabi, I want to say how much I value and respect you whenever I visit SKUAST for the brilliant work you and your team are doing. A recent visit to his lab was revealing. The work he is doing, and he has done, will make every Kashmiri proud.
Ladies and Gentlemen. As a clinician, I see the hope your research brings through its innovations. When you map a new cytokine pathway or a dendritic cell interaction, you aren't just filling a textbook; you are giving my patients their lives back. The biologics and small molecules we use today in the clinic are the 'harvest' of the seeds planted at conferences like this one. You are the architects; we are the builders at the bedside."

"My message to you today is one of Radical Collaboration. The walls between the lab and the clinic must be porous. We, clinicians, have the 'what'—the complex, messy reality of human disease. You, the immunologists, have the 'how'—the fundamental mechanisms of life and defense.

Let this conference at SKIMS be more than a series of lectures. Let it be a collision of ideas. I challenge the young researchers here: don't just look at the cell; look at the patient. And to my fellow clinicians: don't just treat the symptom; understand the signal."

I wish you all very fruitful deliberations. Good luck. God bless.

Address

Dr. Khuroo's Medical Clinic, Sector 1 Colony, Qamarwari, Telephone 7006277331; 7006177742; 0194-2492398
Srinagar
190010

Alerts

Be the first to know and let us send you an email when Dr. Khuroo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr. Khuroo:

Shortcuts

Share

Category